ATE399013T1 - Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose - Google Patents

Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose

Info

Publication number: ATE399013T1
Authority: AT; Austria
Prior art keywords: treatment; multiple sclerosis; tnfalpha; chemically modified; cox
Prior art date: 1997-12-19

Application number

AT98964764T

Other languages

English (en)

Inventor

Ashok Amin

Steven Abramson

Original Assignee

Univ New York

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-19

Filing date

1998-12-17

Publication date

2008-07-15

1998-12-17 Application filed by Univ New York filed Critical Univ New York

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE399013T1 publication Critical patent/ATE399013T1/de

Links

239000004098 Tetracycline Substances 0.000 title abstract 3
235000019364 tetracycline Nutrition 0.000 title abstract 3
150000003522 tetracyclines Chemical class 0.000 title abstract 3
201000006417 multiple sclerosis Diseases 0.000 title 1
229960002180 tetracycline Drugs 0.000 title 1
229930101283 tetracycline Natural products 0.000 title 1
102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 abstract 3
108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 3
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 3
108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 abstract 2
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 2
229960002986 dinoprostone Drugs 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 2
229940040944 tetracyclines Drugs 0.000 abstract 2
108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Virology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT98964764T 1997-12-19 1998-12-17 Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose ATE399013T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6826897P	1997-12-19	1997-12-19

Publications (1)

Publication Number	Publication Date
ATE399013T1 true ATE399013T1 (de)	2008-07-15

Family

ID=22081491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98964764T ATE399013T1 (de)	1997-12-19	1998-12-17	Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose

Country Status (11)

Country	Link
US (1)	US6319910B1 (de)
EP (1)	EP1041991B1 (de)
JP (1)	JP4733266B2 (de)
AT (1)	ATE399013T1 (de)
AU (1)	AU2001599A (de)
CA (1)	CA2316972C (de)
DE (1)	DE69839649D1 (de)
DK (1)	DK1041991T3 (de)
ES (1)	ES2310018T3 (de)
PT (1)	PT1041991E (de)
WO (1)	WO1999030720A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7906481B2 (en) *	1998-09-25	2011-03-15	Sciaticon Ab	Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus
US7811990B2 (en) *	1998-09-25	2010-10-12	Sciaticon Ab	Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus
US7115557B2 (en) *	1998-09-25	2006-10-03	Sciaticon Ab	Use of certain drugs for treating nerve root injury
SE9803710L (sv) *	1998-09-25	2000-03-26	A & Science Invest Ab	Användning av vissa substanser för behandling av nervrotsskador
US6506740B1 (en)	1998-11-18	2003-01-14	Robert A. Ashley	4-dedimethylaminotetracycline derivatives
US6946453B2 (en)	1998-11-18	2005-09-20	Collagenex Pharmaceuticals, Inc.	4-dedimethylaminotracycline derivatives
EP1253921A4 (de) *	2000-01-28	2004-10-13	Merck & Co Inc	Behandlung und prophylaxe des prostatakrebs mit cox-2 selektiven inhibitoren
US6623736B2 (en) *	2000-05-02	2003-09-23	Edward L. Tobinick	Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
US20040033938A1 (en) *	2000-09-12	2004-02-19	Britten Nancy J.	Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
DE60235083D1 (de) *	2001-04-24	2010-03-04	Paratek Pharm Innc	Substituierte tetracyclin-verbindungen zur behandlung von malaria
US8088820B2 (en)	2001-04-24	2012-01-03	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds for the treatment of malaria
JP2004537544A (ja)	2001-07-13	2004-12-16	パラテックファーマシューティカルズインコーポレイテッド	標的治療活性を有するテトラサイクリン化合物
WO2003079984A2 (en) *	2002-03-21	2003-10-02	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
AU2003287218C1 (en) *	2002-10-24	2010-07-15	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds for the treatment of malaria
CA2503446C (en) *	2002-10-24	2012-12-18	Paratek Pharmaceuticals, Inc.	Methods of using substituted tetracycline compounds to modulate rna
US20080153894A1 (en) *	2002-12-19	2008-06-26	Pharmacia Corporation	Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20080249072A1 (en) *	2004-09-22	2008-10-09	Golub Lorne M	Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators
GB0518558D0 (en) *	2005-09-12	2005-10-19	Givaudan Sa	Improvements in or related to organic compounds
EP1986657A4 (de) *	2006-02-16	2011-07-20	Discogen Llc	Verfahren zur behandlung einer unter degenerativen bandscheiben leidenden person mithilfe eines matrix-metallprotease-hemmers
WO2008047340A1 (en) *	2006-10-19	2008-04-24	Mor Research Applications Ltd.	Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4704383A (en) *	1983-12-29	1987-11-03	The Research Foundation Of State University Of New York	Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
JP3016587B2 (ja) *	1989-12-04	2000-03-06	ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク	非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) *	1989-12-04	1994-05-03	The Research Foundation Of State University Of New York	Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JPH0454160A (ja) *	1990-06-21	1992-02-21	Kuraray Co Ltd	テトラサイクリン誘導体
US5045538A (en) *	1990-06-28	1991-09-03	The Research Foundation Of State University Of New York	Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
JPH04178359A (ja) *	1990-07-01	1992-06-25	Kuraray Co Ltd	テトラサイクリン誘導体
US5223248A (en) *	1991-02-11	1993-06-29	The Research Foundation Of State University Of New York	Non-antibacterial tetracycline compositions possessing antiplaque properties
US5258371A (en) *	1992-05-29	1993-11-02	Kuraray Co., Ltd.	Method to reduce connective tissue destruction
DE69304292T2 (de) *	1992-11-17	1997-01-02	Univ New York	Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
JPH0782153A (ja) *	1993-07-20	1995-03-28	Sumio Arai	エンドトキシン中和剤
JP2676093B2 (ja) *	1994-12-05	1997-11-12	ザリサーチファンデーションオブステートユニバーシティオブニューヨーク	動物飼料組成物
JPH08268907A (ja) *	1995-03-31	1996-10-15	Sunstar Inc	歯周組織再生促進剤
US5789395A (en) *	1996-08-30	1998-08-04	The Research Foundation Of State University Of New York	Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5837696A (en) *	1997-01-15	1998-11-17	The Research Foundation Of State University Of New York	Method of inhibiting cancer growth

1998
- 1998-12-17 DK DK98964764T patent/DK1041991T3/da active
- 1998-12-17 CA CA002316972A patent/CA2316972C/en not_active Expired - Fee Related
- 1998-12-17 WO PCT/US1998/026870 patent/WO1999030720A1/en not_active Ceased
- 1998-12-17 AU AU20015/99A patent/AU2001599A/en not_active Abandoned
- 1998-12-17 PT PT98964764T patent/PT1041991E/pt unknown
- 1998-12-17 AT AT98964764T patent/ATE399013T1/de active
- 1998-12-17 DE DE69839649T patent/DE69839649D1/de not_active Expired - Lifetime
- 1998-12-17 ES ES98964764T patent/ES2310018T3/es not_active Expired - Lifetime
- 1998-12-17 JP JP2000538702A patent/JP4733266B2/ja not_active Expired - Fee Related
- 1998-12-17 EP EP98964764A patent/EP1041991B1/de not_active Expired - Lifetime
- 1998-12-17 US US09/213,149 patent/US6319910B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1041991A1 (de)	2000-10-11
JP4733266B2 (ja)	2011-07-27
WO1999030720A9 (en)	1999-10-07
US6319910B1 (en)	2001-11-20
WO1999030720A1 (en)	1999-06-24
DK1041991T3 (da)	2008-07-28
JP2002508327A (ja)	2002-03-19
PT1041991E (pt)	2008-10-03
CA2316972C (en)	2009-02-24
AU2001599A (en)	1999-07-05
WO1999030720A8 (en)	1999-09-02
DE69839649D1 (de)	2008-08-07
CA2316972A1 (en)	1999-06-24
EP1041991B1 (de)	2008-06-25
EP1041991A4 (de)	2002-08-21
ES2310018T3 (es)	2008-12-16

Legal Events

Date

Code

Title

Description

2009-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1041991

Country of ref document: EP

Publication	Publication Date	Title
DE69839649D1 (de)	2008-08-07	Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose
ATE234090T1 (de)	2003-03-15	Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
EA200100573A1 (ru)	2002-02-28	Применение ингибитора циклооксигеназы-2, ингибитора матричной металлопротеиназы, противоопухолевого лекарственного средства и факультативно облучения в качестве комбинированного способа лечения неоплазии
ATE331521T1 (de)	2006-07-15	Behandlung von schmerzen
CY1105501T1 (el)	2010-04-28	Συνδυασμοι φαρμακων (π.χ. chlorpromazine και pentamidine) για την αντιμετωπιση νεοπλαστικων διαταραχων
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE455092T1 (de)	2010-01-15	Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE69508192D1 (de)	1999-04-15	Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
FI970101A0 (fi)	1997-01-10	Uusi farmaseuttinen valmiste kivun hallintaan
ATE527022T1 (de)	2011-10-15	Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
CY1110462T1 (el)	2015-04-29	Θεραπεια της ηπατικης ινωσης με αντισωματα εναντιον της ενσωματινης (ιντεγκρινης) αλφα v βητα 6
WO2002098898A3 (en)	2003-07-03	FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
ATE206107T1 (de)	2001-10-15	Immunotherapeutische arylamide
NO974824D0 (no)	1997-10-17	Arteriovenöse og venös transplantasjonsbehandlinger, fremgangsmåter og blandinger
ATE350030T1 (de)	2007-01-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
EA200300544A1 (ru)	2003-08-28	Эффективные противоопухолевые лекарственные средства
BR9916544A (pt)	2002-01-08	Processo para tratamento de neoplasia em um indivìduo que necessita de tal tratamento, e, combinação
ES2167401T3 (es)	2002-05-16	Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
DE69715000D1 (de)	2002-10-02	Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
DK1404304T3 (da)	2009-07-13	Tablet omfattende cetirizin og pseudoephedrin
ES2124801T3 (es)	1999-02-16	Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
FR2845917B1 (fr)	2006-07-07	Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
DK1053000T3 (da)	2008-09-01	Midler og fremgangsmåder til beskyttelse, behandling og udbedring af bindevæv
EA200200137A1 (ru)	2002-06-27	Лечение невротических нарушений
ATE201559T1 (de)	2001-06-15	Pflanzenbehandlungsmittel